Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$36.8 4.15 | 12.71%
05/03/16 - 02:22 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 10.45B 8.26B 5.77B 3.55B
Cost of Sales 2.23B 2.00B 1.70B 944.78M
Gross Operating Profit 8.22B 6.27B 4.07B 2.60B
Selling, General, and Administrative Expenses 2.70B 2.03B 1.54B 812.86M
Research & Development 334.40M 246.00M 156.78M 268.95M
Operating Income before D & A (EBITDA) 5.18B 3.99B 2.37B 1.52B
Depreciation & Amortization 2.77B 1.81B 2.11B 1.02B
Interest Income 3.30M 5.00M 8.02M 5.99M
Other Income - Net -138.30M 26.70M -75.81M -1.24M
Special Income / Charges -504.50M 227.70M -153.64M 0.00
Total Income Before Interest Expenses (EBIT) 1.41B 2.06B -470.14M 79.17M
Interest Expense 1.56B 971.00M 844.32M 473.40M
Pre-Tax Income -155.30M 1.09B -1.31B -394.23M
Income Taxes 132.50M 180.40M -450.78M -278.20M
Minority Interest 3.90M -1.30M 2.47M 0.00
Net Income From Continuing Operations -287.80M 912.20M -863.67M -116.03M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -287.80M 912.20M -863.67M -116.03M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -291.70M 913.50M -866.14M -116.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
578.60M 1.07B -195.21M 306.97M
Preferred Dividends
Net Income Available To Common -287.80M 912.20M -863.67M -116.03M
Basic EPS from Continuing Ops. -0.85 2.72 -2.70 -0.38
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.85 2.72 -2.70 -0.38
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.85 2.72 -2.70 -0.38
Basic Normalized Net Income/Share 1.71 3.18 -0.61 1.00
EPS fr Continuing Ops. -0.85 2.67 -2.70 -0.38
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.85 2.67 -2.70 -0.38
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.85 2.67 -2.70 -0.38
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.71 3.13 -0.61 1.00
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter